| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 4 | -30.7 K | 100% | $15.28 | -$469 K |
| Net | -4 | -30.7 K | -100% | -$469 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Peter H. Soderberg | Director | $5.24 M | May 17, 2021 | ||
| Daniel L. Reuvers | President and CEO, Director | $3.63 M | -$295 K | -7.51% | Feb 27, 2024 |
| Richard Nigon | Director | $2.39 M | May 17, 2021 | ||
| Roche Kevin H | Director | $1.36 M | Oct 1, 2021 | ||
| Brent Moen | Chief Financial Officer | $1 M | Mar 1, 2023 | ||
| Kristie Burns | Sr. VP Mktg & Clinical Affairs | $899 K | -$97.7 K | -9.8% | May 6, 2024 |
| Elaine M. Birkemeyer | Chief Financial Officer | $838 K | -$41.6 K | -4.73% | May 16, 2024 |
| Sherri Lee Ferstler | Senior VP, Sales | $828 K | Feb 21, 2024 | ||
| Eric Pauls | Senior VP, Sales | $606 K | May 8, 2023 | ||
| Raymond Huggenberger | Director | $578 K | May 8, 2024 | ||
| William W. Burke | Director | $503 K | -$35.2 K | -6.54% | May 8, 2024 |
| Sheri Louise Dodd | Director | $484 K | May 8, 2024 | ||
| David Brent Shafer | Director | $471 K | May 8, 2024 | ||
| Valerie L. Asbury | Director | $471 K | May 8, 2024 | ||
| Deepti Jain | Director | $317 K | May 9, 2022 | ||
| Carmen Volkart | Director | $311 K | May 8, 2024 | ||
| Boyd Vindell Washington | Director | $275 K | May 8, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|